US Patent 9879042 Human iNKT cell activation using glycolipids

Patent 9879042 was granted and assigned to Academia Sinica on January, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Academia Sinica

Current Assignee

Academia Sinica

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9879042

Patent Inventor Names

Chi-Huey Wong0

Tai-Na Wu0

Alice L. Yu0

Kun-Hsien Lin0

Date of Patent

January 30, 2018

Patent Application Number

14847835

Date Filed

September 8, 2015

Patent Citations Received

‌

US Patent 11884739 Anti-CD20 glycoantibodies and uses thereof

Patent Primary Examiner

‌

Noble E Jarrell

Patent abstract

Glycosphingolipids (GSLs) compositions and methods for iNKT-independent induction of chemokines are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9879042 Human iNKT cell activation using glycolipids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API